| Upcoming events on MERCK & CO., INC. |
|
| 05/25/21 | 09:00am | | Annual General Meeting |
| 06/07/21 | 04:00pm | | ASCO Event |
| 07/29/21 | | Interim 2021 Earnings Release |
| 07/29/21 | 08:00am | | Interim 2021 Earnings Call |
|
| Past events on MERCK & CO., INC. |
|
| 05/03/21 | 10:00am | | Investor Day |
| 04/29/21 | 08:00am | | Q1 2021 Earnings Call |
| 04/29/21 | 06:30am | | Q1 2021 Earnings Release |
| 03/15/21 | 07:00am | | Merck & Co and Gilead Joint Venture Agreement Call |
|
| Upcoming sector events for MERCK & CO., INC. |
|
|
| |
|
| Past sector events for MERCK & CO., INC. |
|
|
|
|
|
| Annual results | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 (e) |
Sales
M $ |
Released
Forecast
Spread | 39 807
39 991
-0,46% | 40 122
40 205
-0,21% | 42 294
42 234
0,14% | 46 840
46 818
0,05% | 47 994
48 177
-0,38% |
51 892
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 19 154
19 083
0,37% | 15 131
15 472
-2,2% | 15 781
15 310
3,1% | 19 572
18 761
4,3% | 20 570
19 815
3,8% |
22 051
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 13 713
13 698
0,11% | 13 551
13 722
-1,2% | 13 926
13 815
0,80% | 15 920
16 276
-2,2% | 16 945
17 366
-2,4% |
19 413
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 7 499
7 288
2,9% | 6 747
6 720
0,40% | 8 701
8 296
4,9% | 11 464
12 277
-6,6% | 8 791
14 906
-41% |
16 992
|
Net income
M $ |
Released
Forecast
Spread | 5 691
5 779
-1,5% | 2 568
5 147
-50% | 6 220
6 462
-3,7% | 9 843
9 957
-1,1% | 7 067
12 094
-42% |
14 041
|
EPS
$ |
Released
Forecast
Spread | 2,04
2,03
0,57% | 0,93
1,85
-50% | 2,32
2,44
-5,0% | 3,81
3,83
-0,52% | 2,78
4,71
-41% |
5,37
| | Announcement Date | 02/02/2017 | 02/02/2018 | 02/01/2019 | 02/05/2020 | 02/04/2021 | |
|
|
|
| Quarterly results | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) | 2022 Q1 (e) | 2022 Q2 (e) |
Sales
M $ |
Released
Forecast
Spread | 10 998
10 929
0,63% | 10 816
10 452
3,5% | 11 760
10 943
7,5% | 12 397
11 593
6,9% | 11 868
11 927
-0,49% | 12 057
11 458
5,2% | 10 872
10 657
2,0% | 12 551
12 213
2,8% | 12 514
12 668
-1,2% | 12 080
12 648
-4,5% |
12 627
|
13 456
|
13 524
|
12 745
|
12 788
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 4 064
3 762
8,0% | 4 324
3 759
15% | 4 665
4 072
15% | 5 474
4 639
18% | 4 336
4 676
-7,3% | 4 802
4 715
1,8% | 4 707
3 911
20% | 5 744
4 862
18% | 4 608
4 606
0,04% | 5 220
5 416
-3,6% |
5 411
|
6 253
|
5 576
|
|
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 3 489
3 371
3,5% | 3 823
3 390
13% | 4 070
3 646
12% | 4 629
3 989
16% | 3 400
3 777
-10,0% | 3 981
4 205
-5,3% | 3 659
3 238
13% | 4 892
4 342
13% | 3 704
4 047
-8,5% | 4 290
4 844
-11% |
4 791
|
5 607
|
5 095
|
|
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread |
| 3 067
2 984
2,8% |
|
|
|
|
|
|
|
|
4 247
|
3 775
|
3 880
|
|
|
Net income
M $ |
Released
Forecast
Spread | 1 827
|
|
| 1 901
2 546
-25% | 2 357
2 458
-4,1% | 3 219
2 856
13% | 3 002
2 323
29% | 2 941
2 575
14% | -2 094
2 773
-176% | 3 179
3 712
-14% |
3 494
|
3 112
|
3 263
|
|
|
EPS
$ |
Released
Forecast
Spread | 0,69
0,85
-19% | 1,12
0,88
27% | 1,03
0,99
4,0% | 0,74
0,96
-23% | 0,92
0,94
-1,8% | 1,26
1,12
13% | 1,18
0,91
29% | 1,16
1,02
14% | -0,83
1,05
-179% | 1,25
1,43
-13% |
1,16
|
1,38
|
1,35
|
1,29
|
1,30
| | Announcement Date | 02/01/2019 | 04/30/2019 | 07/30/2019 | 10/29/2019 | 02/05/2020 | 04/28/2020 | 07/31/2020 | 10/27/2020 | 02/04/2021 | 04/29/2021 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
|
Climate activists urge BlackRock, Vanguard to vote against Exxon directors |
|
MERCK AND COMPANY
Leader in oncology, modest valuation |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous period
